Award
National Institute of Neurological Disorders and Stroke 5U44NS129628-04
Preclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding
Recipient
RESEARCH TRIANGLE PARK
Award Amount
$199,520.00
Ceiling
$199,520.00
Awarded
May 05, 2026
Identifier
5U44NS129628-04
Award for developing a novel drug for on-demand voiding to treat bowel and bladder retention disorders, funded by NINDS with a total amount of $199,520.
Description
The project aims to develop a pharmaceutical treatment for bowel and bladder retention disorders, including preclinical development and filing an IND for DTI-117. Funded by NINDS under PAR-21-233, scheduled for May 5, 2026, with a project duration from March 1, 2023, to February 28, 2027.